Literature DB >> 8449717

A survey of the Czechoslovak follow-up of lung cancer mortality in uranium miners.

J Sevc1, L Tomasek, E Kunz, V Placek, D Chmelevsky, D Barclay, A M Kellerer.   

Abstract

The major Czechoslovak cohort of uranium miners (S-cohort) is surveyed in terms of diagrams illustrating dependences on calendar year, age, and exposure to radon and radon progeny. An analysis of the dose dependence of lung cancer mortality is performed by nonparametric and, subsequently, by parametric methods. In the first step, two-dimensional isotonic regression is employed to derive the lung cancer mortality rate and the relative excess risk as functions of age attained and of lagged cumulated exposure. In a second step, analytical fits in terms of relative risk models are derived. The treatment is largely analogous to the methods applied by the BEIR IV Committee to other major cohorts of uranium miners. There is a marked dependence of the excess risk on age attained and on time since exposure. A specific characteristic of the Czechoslovak data is the nonlinearity of the dependence of the lung cancer excess risk on the cumulated exposure; exposures on the order of 100 working level months or less appear to be more effective per working level month than larger exposures but, in the absence of an internal control group, this cannot be excluded to be due to confounders such as smoking or environmental exposures. A further notable observation is the association of larger excess risks with longer protraction of the exposures.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449717     DOI: 10.1097/00004032-199304000-00002

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  9 in total

1.  Lung cancer mortality among nuclear workers of the Mayak facilities in the former Soviet Union. An updated analysis considering smoking as the main confounding factor.

Authors:  M Kreisheimer; M E Sokolnikov; N A Koshurnikova; V F Khokhryakov; S A Romanow; N S Shilnikova; P V Okatenko; E A Nekolla; A M Kellerer
Journal:  Radiat Environ Biophys       Date:  2003-07-08       Impact factor: 1.925

2.  Studies of radon-exposed miner cohorts using a biologically based model: comparison of current Czech and French data with historic data from China and Colorado.

Authors:  W F Heidenreich; L Tomásek; A Rogel; D Laurier; M Tirmarche
Journal:  Radiat Environ Biophys       Date:  2004-11-30       Impact factor: 1.925

3.  The inverse dose-rate effect for radon induced lung cancer: a modified approach for risk modelling.

Authors:  M Kreisheimer
Journal:  Radiat Environ Biophys       Date:  2006-03-08       Impact factor: 1.925

4.  Mortality in uranium miners in west Bohemia: a long-term cohort study.

Authors:  L Tomásek; A J Swerdlow; S C Darby; V Placek; E Kunz
Journal:  Occup Environ Med       Date:  1994-05       Impact factor: 4.402

5.  A hybrid likelihood algorithm for risk modelling.

Authors:  A M Kellerer; M Kreisheimer; D Chmelevsky; D Barclay
Journal:  Radiat Environ Biophys       Date:  1995-03       Impact factor: 1.925

Review 6.  Does occupational exposure to dust prevent colorectal cancer?

Authors:  M M Finkelstein
Journal:  Occup Environ Med       Date:  1995-03       Impact factor: 4.402

7.  Radon and cancer mortality among underground uranium miners in the Příbram region of the Czech Republic.

Authors:  Kaitlin Kelly-Reif; Dale P Sandler; David Shore; Mary K Schubauer-Berigan; Melissa A Troester; Leena Nylander-French; David B Richardson
Journal:  Am J Ind Med       Date:  2020-08-09       Impact factor: 3.079

Review 8.  Modifiers of exposure-response estimates for lung cancer among miners exposed to radon progeny.

Authors:  R W Hornung; J Deddens; R Roscoe
Journal:  Environ Health Perspect       Date:  1995-03       Impact factor: 9.031

9.  Recent results from the study of West Bohemian uranium miners exposed to radon and its progeny.

Authors:  L Tomásek; S C Darby
Journal:  Environ Health Perspect       Date:  1995-03       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.